颅内脑膜瘤患者长期疾病负担的决定因素与预测模型
本研究基于190例WHO I/II级颅内脑膜瘤患者的横断面多中心数据二次分析,中位干预后9年评估健康相关生活质量(HRQoL)与神经认知功能。多变量回归识别出社会人口学特征、手术并发症、再手术、放疗、水肿及末次MRI肿瘤直径较大为主要决定因素,并构建了区分能力中等/良好的预测模型(HRQoL C统计量0.73,95%CI 0.65-0.81;神经认知C统计量0.78,95%CI 0.70-0.85)。
要点
- 社会人口学特征、手术并发症、再手术、放疗、水肿及末次MRI肿瘤直径较大与长期HRQoL或神经认知受损相关。
- 预测模型可中等/良好区分个体患者是否存在长期HRQoL或神经认知受损。
- 并非所有预测因子(如肿瘤位置)同时也是决定因素。
核心结论
- 识别的决定因素有助于临床医生更好地理解脑膜瘤长期疾病负担。
- 预测模型有助于早期识别存在长期神经认知或HRQoL受损风险的个体患者,促进针对性信息提供和有限支持护理服务的分配。
研究设计与样本
- 横断面多中心研究的二次数据分析,纳入颅内WHO I/II级脑膜瘤患者190例,中位干预后9年评估HRQoL(Short-Form 36)和神经认知功能(标准化测试组合)。
- 使用多变量回归模型评估校正混杂因素后的决定因素,并构建预测模型,以C统计量评价。
主要发现
- 主要决定因素包括患者社会人口学特征、手术并发症、再手术、放疗、水肿存在以及末次MRI肿瘤直径较大。
- 预测模型区分个体患者有无HRQoL受损的C统计量为0.73(95%CI 0.65-0.81),区分神经认知功能受损的C统计量为0.78(95%CI 0.70-0.85)。
- 模型中的部分预测因子(如肿瘤位置)并非决定因素。
关键数值与推荐
- HRQoL预测模型C统计量0.73(95%CI 0.65-0.81)。
- 神经认知功能预测模型C统计量0.78(95%CI 0.70-0.85)。
临床怎么用
- 临床可利用识别的决定因素理解脑膜瘤患者长期疾病负担。
- 预测模型可辅助早期识别长期神经认知或HRQoL受损高风险个体,用于针对性信息提供和支持护理资源分配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Meningioma is a heterogeneous disease and patients may suffer from long-term tumor- and treatment-related sequelae. To help identify patients at risk for these late effects, we first assessed variables associated with impaired long-term health-related quality of life (HRQoL) and impaired neurocognitive function on group level (i.e. determinants). Next, prediction models were developed to predict the risk for long-term neurocognitive or HRQoL impairment on individual patient-level. METHODS: Secondary data analysis of a cross-sectional multicenter study with intracranial WHO grade I/II meningioma patients, in which HRQoL (Short-Form 36) and neurocognitive functioning (standardized test battery) were assessed. Multivariable regression models were used to assess determinants for these outcomes corrected for confounders, and to build prediction models, evaluated with C-statistics. RESULTS: Data from 190 patients were analyzed (median 9 years after intervention). Main determinants for poor HRQoL or impaired neurocognitive function were patients' sociodemographic characteristics, surgical complications, reoperation, radiotherapy, presence of edema, and a larger tumor diameter on last MRI. Prediction models with a moderate/good ability to discriminate between individual patients with and without impaired HRQoL (C-statistic 0.73, 95% CI 0.65 to 0.81) and neurocognitive function (C-statistic 0.78, 95%CI 0.70 to 0.85) were built. Not all predictors (e.g. tumor location) within these models were also determinants. CONCLUSIONS: The identified determinants help clinicians to better understand long-term meningioma disease burden. Prediction models can help early identification of individual patients at risk for long-term neurocognitive or HRQoL impairment, facilitating tailored provision of information and allocation of scarce supportive care services to those most likely to benefit.
引用
- Zamanipoor Najafabadi AH, van der Meer PB, Boele FW, et al. Determinants and predictors for the long-term disease burden of intracranial meningioma patients. J Neurooncol. 2020. PMID: 33073326. doi:10.1007/s11060-020-03650-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。